<DOC>
	<DOCNO>NCT02357004</DOCNO>
	<brief_summary>The purpose protocol test whether patient hypertension refractory antihypertensive treatment evidence excessive sympathetic ( i.e. , nervous system ) activity .</brief_summary>
	<brief_title>Mechanisms Refractory Hypertension ( Carvedilol )</brief_title>
	<detailed_description>Refractory hypertension refers high blood pressure fail conventional antihypertensive therapy . In retrospective assessment patient clinic observe rest clinic heart rate higher patient refractory hypertension compare patient control hypertension . This observation lead hypothesis refractory hypertension cause excessive sympathetic output . This protocol design test hypothesis compare BP response carvedilol verse chlorthalidone patient refractory hypertension . If extreme treatment resistance neurogenic etiology , significantly large BP response carvedilol occur compare chlorthalidone .</detailed_description>
	<mesh_term>Carvedilol</mesh_term>
	<mesh_term>Chlorthalidone</mesh_term>
	<criteria>Uncontrolled clinic BP ( &gt; 140/90 mmHg ) Receiving 5 antihypertensive agent include ACE inhibitor ARB , calcium channel blocker , chlorthalidone 25 mg Current use alpha beta combine alphabeta antagonist Known allergy alphabeta antagonist CKD ( eGFR &lt; 40 ml/min/m2 ) MI , stroke episode CHF exacerbation within 3 month Bradycardia &lt; 50 bpm ; history 2nd 3rd degree heart block unless treat pacemaker Pregnant breastfeeding woman Known hypersensitivity chlorthalidone sulfonamidederived drug</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>